ICON Gross Profit 2011-2025 | ICLR
ICON annual/quarterly gross profit history and growth rate from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- ICON gross profit for the quarter ending September 30, 2025 was $0.554B, a 6.25% decline year-over-year.
- ICON gross profit for the twelve months ending September 30, 2025 was $2.274B, a 7.46% decline year-over-year.
- ICON annual gross profit for 2024 was $2.436B, a 1.51% increase from 2023.
- ICON annual gross profit for 2023 was $2.4B, a 8.39% increase from 2022.
- ICON annual gross profit for 2022 was $2.214B, a 46.82% increase from 2021.
|
ICON Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $2,436 |
| 2023 | $2,400 |
| 2022 | $2,214 |
| 2021 | $1,508 |
| 2020 | $817 |
| 2019 | $832 |
| 2018 | $778 |
| 2017 | $731 |
| 2016 | $705 |
| 2015 | $666 |
| 2014 | $600 |
| 2013 | $491 |
| 2012 | $397 |
| 2011 | $334 |
| 2010 | $359 |
|
ICON Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $554 |
| 2025-06-30 | $562 |
| 2025-03-31 | $559 |
| 2024-12-31 | $599 |
| 2024-09-30 | $591 |
| 2024-06-30 | $627 |
| 2024-03-31 | $619 |
| 2023-12-31 | $621 |
| 2023-09-30 | $606 |
| 2023-06-30 | $591 |
| 2023-03-31 | $583 |
| 2022-12-31 | $581 |
| 2022-09-30 | $567 |
| 2022-06-30 | $543 |
| 2022-03-31 | $523 |
| 2021-12-31 | $528 |
| 2021-09-30 | $508 |
| 2021-06-30 | $240 |
| 2021-03-31 | $232 |
| 2020-12-31 | $225 |
| 2020-09-30 | $208 |
| 2020-06-30 | $174 |
| 2020-03-31 | $210 |
| 2019-12-31 | $217 |
| 2019-09-30 | $211 |
| 2019-06-30 | $204 |
| 2019-03-31 | $199 |
| 2018-12-31 | $200 |
| 2018-09-30 | $196 |
| 2018-06-30 | $192 |
| 2018-03-31 | $190 |
| 2017-12-31 | $188 |
| 2017-09-30 | $181 |
| 2017-06-30 | $181 |
| 2017-03-31 | $181 |
| 2016-12-31 | $184 |
| 2016-09-30 | $177 |
| 2016-06-30 | $173 |
| 2016-03-31 | $172 |
| 2015-12-31 | $174 |
| 2015-09-30 | $168 |
| 2015-06-30 | $164 |
| 2015-03-31 | $160 |
| 2014-12-31 | $160 |
| 2014-09-30 | $158 |
| 2014-06-30 | $149 |
| 2014-03-31 | $133 |
| 2013-12-31 | $130 |
| 2013-09-30 | $126 |
| 2013-06-30 | $120 |
| 2013-03-31 | $217 |
| 2012-12-31 | $108 |
| 2012-09-30 | $102 |
| 2012-06-30 | $97 |
| 2012-03-31 | $181 |
| 2011-12-31 | $84 |
| 2011-09-30 | $82 |
| 2011-06-30 | $82 |
| 2011-03-31 | $161 |
| 2010-12-31 | $92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.197B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $154.973B | 28.46 |
| HCA Healthcare (HCA) | United States | $108.075B | 17.89 |
| CVS Health (CVS) | United States | $101.885B | 11.72 |
| Elevance Health (ELV) | United States | $72.812B | 10.68 |
| Cencora (COR) | United States | $70.459B | 22.73 |
| Natera (NTRA) | United States | $28.914B | 0.00 |
| DiDi Global (DIDIY) | China | $26.262B | 21.46 |
| Labcorp Holdings (LH) | United States | $22.051B | 16.81 |
| Medpace Holdings (MEDP) | United States | $16.833B | 41.79 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.005B | 0.00 |
| Solventum (SOLV) | United States | $12.806B | 12.43 |
| Viatris (VTRS) | United States | $12.681B | 4.73 |
| CochLear (CHEOY) | Australia | $12.223B | 0.00 |
| Revvity (RVTY) | United States | $10.672B | 19.65 |
| HealthEquity (HQY) | United States | $8.659B | 34.65 |
| Charles River Laboratories (CRL) | United States | $8.440B | 16.26 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.989B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.969B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.067B | 36.17 |
| Bausch + Lomb (BLCO) | Canada | $5.880B | 38.60 |
| Sotera Health (SHC) | United States | $4.617B | 22.26 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.944B | 69.26 |
| Alignment Healthcare (ALHC) | United States | $3.322B | 0.00 |
| Concentras Parent (CON) | United States | $2.558B | 15.97 |
| Premier (PINC) | United States | $2.326B | 22.54 |
| Progyny (PGNY) | United States | $2.075B | 40.80 |
| Surgery Partners (SGRY) | United States | $2.051B | 26.43 |
| Ardent Health (ARDT) | United States | $2.011B | 6.57 |
| Organon (OGN) | United States | $2.004B | 2.11 |
| Pediatrix Medical (MD) | United States | $1.949B | 11.64 |
| Establishment Labs Holdings (ESTA) | $1.836B | 0.00 | |
| PACS (PACS) | United States | $1.747B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.326B | 0.00 |
| Omada Health (OMDA) | $1.242B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.063B | 17.00 |
| Embecta (EMBC) | United States | $0.848B | 4.97 |
| CareDx (CDNA) | United States | $0.839B | 13.71 |
| InnovAge Holding (INNV) | United States | $0.772B | 0.00 |
| Nutex Health (NUTX) | United States | $0.676B | 10.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.637B | 8.78 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.562B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Pomdoctor - (POM) | China | $0.457B | 0.00 |
| CryoPort (CYRX) | United States | $0.442B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 18.30 |
| Auna S.A (AUNA) | Luxembourg | $0.387B | 5.81 |
| So-Young (SY) | China | $0.378B | 0.00 |
| SBC Medicals (SBC) | United States | $0.351B | 7.68 |
| Oncology Institute (TOI) | United States | $0.321B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.305B | 0.00 |
| KindlyMD (NAKA) | United States | $0.295B | 0.00 |
| Agilon Health (AGL) | United States | $0.260B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.169B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| DocGo (DCGO) | United States | $0.106B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.58 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |